Eli Lilly and Co (LLY) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

LLY Eli Lilly and Co

Watchlist

844.640
+72.500+9.39%

Trading Aug 8 14:21 ET

802.75BMarket Cap104.02P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Market Mover | Eli Lilly Shares Surge 12% as the Company Raises Full-Year Revenue Guidance by $3 Billion
Moomoo NewsAug 8 09:07 ET · Movers
Eli Lilly's Stock Soars as Mounjaro, Zepbound Sales Lead to a Big Profit Beat
MarketWatchAug 8 07:57 ET
Lilly Alzheimer's Asset Targeting Tau Protein Fails in Phase 2
Seeking Alpha18minutes ago
10 Health Care Stocks Whale Activity In Today's Session
Benzinga46minutes ago
Trending Stocks Today | MGO Global Surges 59.05%
Moomoo News13:10 ET
Express News | Benzinga Market Summary: Jobless Claims Come In Below Estimates, Semi Stocks Gain, Lilly Raises Guidance
Benzinga13:04 ET

Comments

103288715

11 minutes ago

$Eli Lilly and Co (LLY.US)$ when i sell everything goes up and whenever i buy everything goes down

Luzi Ann Santos

2 hours ago

Columns Eli Lilly's 7% Share Price Jump Spurs Heavy Buying of Call Options

Eli Lilly ( $Eli Lilly and Co (LLY.US)$) is seeing heavy buying of call options that signal optimism of continued rally for a stock that's already jumped more than 7% Thursday.
The stock climbed to $29.30 around noon Thursday after the company raised its full year revenue outlook by about $3 billion, surpassing even the most optimistic analyst estimate and delivered top and bottom-line results for the second quarter that blew past W...

103288715

2 hours ago

$Eli Lilly and Co (LLY.US)$ common fly 🚀

Kevin Travers

2 hours ago

Columns Earnings Bite Consumer Stocks, Besides Weightloss | Moovin Stonks

Good morning, traders. Happy Thursday, the market is trying to climb up after falling back. The Nasdaq and tech stocks were still in correction territory from their heights in the lush days of July. My name is Kevin Travers, here are moovin' stonks.
Eli Lilly $Eli Lilly and Co (LLY.US)$ posted a Q2 earnings beat, boosted by demand for the company's Mounjaro diabetes treatment and weight-loss drug Zepbound. The stock climbed 8%, and ...